The drug, Ibtrozi, will now vie for market share in an indication where multiple large pharmaceutical companies have already struggled to grow sales.

Reduce your other risk factors. Tobacco and alcohol use are some of the strongest lifestyle risk factors for head and neck ...

Nuvation Bio (NUVB) wins U.S. FDA approval for its oral antitumor agent Ibtrozi as a treatment for certain patients with ...

In the 1950s, a Chinese American physician refused to get with the program at the National Cancer Institute, and ultimately ...

FN Media Group News Commentary - The global oncology market is undergoing rapid growth, mainly due to the increasing number of cancer cases around the world. The World Health Organization estimates ...

Scientists in Japan have discovered that a natural compound found in a type of ginger called kencur can throw cancer cells ...

Medicus Pharm submitted a product development plan to the FDA for an Investigational New Animal Drug designation.

Brain tumors are not only treatable but potentially curable with the evolving therapies explains Dr V Naveen Reddy from ...

The US-based biotech company has submitted an application to the Saudi Food and Drug Authority (SFDA) for Breakthrough ...

Pharmaceutical Co. Ltd.’s LYN/BTK dual inhibitor, DZD-8586, saw tumor shrinkage in 94.1% of patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma following ...

AI apps that can detect skin cancer can be manipulated and potentially miss cases of melanoma, a serious skin cancer.

When it comes to the use of PD-1 inhibitors in stomach cancer, the FDA has put its money where its mouth is. | After ...